Published in Clin Vaccine Immunol on July 02, 2008
Controlled human infection and rechallenge with Streptococcus pneumoniae reveals the protective efficacy of carriage in healthy adults. Am J Respir Crit Care Med (2013) 1.84
Older adults have a low capacity to opsonize pneumococci due to low IgM antibody response to pneumococcal vaccinations. Infect Immun (2010) 1.49
Naturally Acquired Human Immunity to Pneumococcus Is Dependent on Antibody to Protein Antigens. PLoS Pathog (2017) 1.41
How sex and age affect immune responses, susceptibility to infections, and response to vaccination. Aging Cell (2015) 1.34
Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun (2008) 1.33
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines. Clin Vaccine Immunol (2009) 1.25
Interaction of pneumococcal histidine triad proteins with human complement. Infect Immun (2010) 1.05
The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun (2010) 1.05
Exposure to poultry dust and health effects in poultry workers: impact of mould and mite allergens. Int Arch Occup Environ Health (2009) 0.99
Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines. Clin Vaccine Immunol (2010) 0.98
Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infect Immun (2010) 0.93
Longitudinal analysis of pneumococcal antibodies during community-acquired pneumonia reveals a much higher involvement of Streptococcus pneumoniae than estimated by conventional methods alone. Clin Vaccine Immunol (2011) 0.91
Plasma biomarkers of mouse aging. Age (Dordr) (2010) 0.90
Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol (2012) 0.88
Specific antibody deficiency in children with recurrent respiratory infections: a controlled study with follow-up. Clin Exp Immunol (2013) 0.87
Risk factors for death from invasive pneumococcal disease, Europe, 2010. Emerg Infect Dis (2015) 0.86
Association of serotype-specific antibody concentrations and functional antibody titers with subsequent pneumococcal carriage in toddlers immunized with a 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol (2011) 0.82
Concentration and high avidity of pneumococcal antibodies persist at least 4 years after immunization with pneumococcal conjugate vaccine in infancy. Clin Vaccine Immunol (2013) 0.81
Factors Affecting Anti-Glycan IgG and IgM Repertoires in Human Serum. Sci Rep (2016) 0.81
Terminal deletion of 11q with significant late-onset combined immune deficiency. J Clin Immunol (2014) 0.80
Immune defects in the risk of infection and response to vaccination in monoclonal gammopathy of undetermined significance and multiple myeloma. Front Immunol (2014) 0.79
Persistent Sex Disparities in Invasive Pneumococcal Diseases in the Conjugate Vaccine Era. J Infect Dis (2016) 0.78
Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age. J Immunol (2016) 0.78
Dynamics and Determinants of Pneumococcal Antibodies Specific against 13 Vaccine Serotypes in the Pre-Vaccination Era. PLoS One (2016) 0.77
Sex and Gender Impact Immune Responses to Vaccines Among the Elderly. Physiology (Bethesda) (2015) 0.77
Role of Natural Autoantibodies and Natural IgM Anti-Leucocyte Autoantibodies in Health and Disease. Front Immunol (2016) 0.77
Pneumococcal Vaccination Guidance for Post-Acute and Long-Term Care Settings: Recommendations From AMDA's Infection Advisory Committee. J Am Med Dir Assoc (2017) 0.75
Age-related changes in lymphocyte development and function. Nat Immunol (2004) 6.16
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med (1991) 6.07
Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis. JAMA (1996) 5.31
Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. JAMA (2001) 4.90
The aging immune system: primer and prospectus. Science (1996) 4.86
Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med (2000) 4.20
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med (2003) 3.64
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin Infect Dis (1999) 3.15
Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol (1993) 2.90
Peripheral development of B cells in mouse and man. Immunol Rev (2004) 2.74
Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis (2005) 2.29
Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis (1985) 2.26
The contribution of smoking and exposure to tobacco smoke to Streptococcus pneumoniae and Haemophilus influenzae carriage in children and their mothers. Clin Infect Dis (2006) 2.12
Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis (2000) 2.11
Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine (2000) 2.07
Increased prevalence of pediatric pneumococcal serotypes in elderly adults. Clin Infect Dis (2005) 2.03
Nasopharyngeal carriage of Streptococcus pneumoniae by adults and children in community and family settings. Clin Infect Dis (2004) 1.95
A general approach to standardization of the solid-phase radioimmunoassay for quantitation of class-specific antibodies. J Immunol Methods (1981) 1.93
Risk factors for pneumonia in the elderly. Am J Med (1994) 1.89
Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clin Exp Immunol (2007) 1.82
Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol (2005) 1.71
Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis (2008) 1.55
Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. J Infect Dis (2001) 1.51
Standardization of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J (1989) 1.51
The role of age in susceptibility to pneumococcal infections. Age Ageing (1992) 1.46
Risk factors for acquiring pneumococcal infections. Arch Intern Med (1986) 1.45
The loss of IgM memory B cells correlates with clinical disease in common variable immunodeficiency. J Allergy Clin Immunol (2005) 1.43
International Circumpolar Surveillance System for invasive pneumococcal disease, 1999-2005. Emerg Infect Dis (2008) 1.34
Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera. Clin Vaccine Immunol (2006) 1.30
Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya. Infect Immun (2004) 1.22
Changes in the B-cell repertoire with age. Vaccine (2000) 1.19
Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect Immun (1997) 1.19
Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J Infect Dis (1996) 1.15
Assignment of weight-based antibody units for 13 serotypes to a human antipneumococcal standard reference serum, lot 89-S(f). Clin Diagn Lab Immunol (2004) 1.15
The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. J Immunol (1976) 1.03
Infections in the elderly. Clin Infect Dis (1996) 1.00
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccine. Clin Vaccine Immunol (2007) 0.97
Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis (1996) 0.96
Risk factors for invasive pneumococcal disease among Navajo adults. Am J Epidemiol (2007) 0.92
Effect of age on the expressed B cell repertoire: role of B cell subsets. Int Immunol (1993) 0.91
Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol (1987) 0.90
The immune response in NZB mice of different ages to thymus-dependent and thymus-independent phosphorylcholine antigens. Immunology (1978) 0.85
Epidemiology of invasive Streptococcus pneumoniae infections in adults in Finland. Epidemiol Infect (1997) 0.85
Long-term outcome associated with early repolarization on electrocardiography. N Engl J Med (2009) 4.53
Dietary intervention in infancy and later signs of beta-cell autoimmunity. N Engl J Med (2010) 4.16
Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home study. Hypertension (2010) 3.82
Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology (2008) 3.80
Flavonoid intake and risk of chronic diseases. Am J Clin Nutr (2002) 3.57
Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Lab Immunol (2003) 3.27
Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr (2007) 3.16
Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care (2007) 3.10
Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA (2005) 3.01
Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine (2003) 2.87
The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med (2010) 2.84
The fundamental link between pneumococcal carriage and disease. Expert Rev Vaccines (2012) 2.79
Whole-grain and fiber intake and the incidence of type 2 diabetes. Am J Clin Nutr (2003) 2.62
Dietary antioxidant intake and risk of type 2 diabetes. Diabetes Care (2004) 2.48
Incidence of schizophrenia in a nationwide cohort of patients with type 1 diabetes mellitus. Arch Gen Psychiatry (2007) 2.45
Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome. Circulation (2011) 2.38
Antibody response to 7-valent conjugated pneumococcal vaccine in patients with chronic lymphocytic leukaemia. Vaccine (2007) 2.07
Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol (2009) 2.06
Quantitative and qualitative anamnestic immune responses to pneumococcal conjugate vaccine in HIV-infected and HIV-uninfected children 5 years after vaccination. J Infect Dis (2009) 1.82
Dietary patterns and the incidence of type 2 diabetes. Am J Epidemiol (2005) 1.81
QRS-T angle as a predictor of sudden cardiac death in a middle-aged general population. Europace (2011) 1.68
Cardiovascular risk factors and low-back pain in a long-term follow-up of industrial employees. Scand J Work Environ Health (2006) 1.68
Predictive value of electrocardiographic QT interval and T-wave morphology parameters for all-cause and cardiovascular mortality in a general population sample. Heart Rhythm (2009) 1.68
Prediction of type 1 diabetes in the general population. Diabetes Care (2010) 1.66
Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies. Vaccine (2007) 1.63
Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry (2007) 1.61
Optimal schedule for home blood pressure measurement based on prognostic data: the Finn-Home Study. Hypertension (2011) 1.57
A nationwide survey of mortality in acromegaly. J Clin Endocrinol Metab (2005) 1.51
Increasing resources effected equity in access to revascularizations for patients with diabetes. Scand Cardiovasc J (2010) 1.45
Coronary heart disease: from a disease of middle-aged men in the late 1970s to a disease of elderly women in the 2000s. Eur Heart J (2005) 1.44
Prevalence and determinants of isolated clinic hypertension in the Finnish population: the Finn-HOME study. J Hypertens (2006) 1.43
Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants. J Infect Dis (2010) 1.39
Obesity history as a predictor of walking limitation at old age. Obesity (Silver Spring) (2007) 1.38
Polychlorinated biphenyls in prospectively collected serum and Parkinson's disease risk. Mov Disord (2012) 1.38
Multilaboratory evaluation of a viability assay for measurement of opsonophagocytic antibodies specific to the capsular polysaccharides of Streptococcus pneumoniae. Clin Diagn Lab Immunol (2003) 1.38
Streptococcus pneumoniae capsular serotype 19F is more resistant to C3 deposition and less sensitive to opsonophagocytosis than serotype 6B. Infect Immun (2008) 1.33
Intraventricular conduction delay in a standard 12-lead electrocardiogram as a predictor of mortality in the general population. Circ Arrhythm Electrophysiol (2011) 1.31
Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J (2005) 1.31
Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines. Clin Vaccine Immunol (2009) 1.25
Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infect Immun (2005) 1.21
Long-term mortality in nationwide cohorts of childhood-onset type 1 diabetes in Japan and Finland. Diabetes Care (2003) 1.21
Altered age-related blood pressure pattern in type 1 diabetes. Circulation (2004) 1.15
NPAS2 and PER2 are linked to risk factors of the metabolic syndrome. J Circadian Rhythms (2009) 1.15
Aging reduces the functionality of anti-pneumococcal antibodies and the killing of Streptococcus pneumoniae by neutrophil phagocytosis. Vaccine (2011) 1.12
Low metacarpal index predicts hip fracture: a prospective population study of 3,561 subjects with 15 years of follow-up. Acta Orthop (2006) 1.11
Seasonal changes in mood and behavior are linked to metabolic syndrome. PLoS One (2008) 1.11
The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol (2009) 1.10
A nationwide population-based survey on visual acuity, near vision, and self-reported visual function in the adult population in Finland. Ophthalmology (2005) 1.09
Depression and C-reactive protein: population-based Health 2000 Study. Psychosom Med (2009) 1.08
High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med (2009) 1.08
Specificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children. Clin Diagn Lab Immunol (2002) 1.08
Antibodies to periodontal pathogens and stroke risk. Stroke (2004) 1.07
Frequency of systemic vascular diseases in patients with primary open-angle glaucoma and exfoliation glaucoma. Acta Ophthalmol (2008) 1.07
Association between body weight and periodontal infection. J Clin Periodontol (2008) 1.06
Widening socioeconomic mortality disparity among diabetic people in Finland. Eur J Public Health (2003) 1.06
Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children. Vaccine (2005) 1.06
Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis. Infect Immun (2005) 1.06
Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine. Vaccine (2003) 1.05
Interaction of pneumococcal histidine triad proteins with human complement. Infect Immun (2010) 1.05
The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun (2010) 1.05
Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes (2006) 1.05
Prognosis of unrecognized coeliac disease as regards mortality: a population-based cohort study. Ann Med (2009) 1.04
Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents. Diabetes Care (2010) 1.04
Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children. Vaccine (2009) 1.03
Antibodies to pneumococcal surface protein A families 1 and 2 in serum and saliva of children and the risk of pneumococcal acute otitis media. J Infect Dis (2007) 1.03
Sagittal abdominal diameter as a new predictor for incident diabetes. Diabetes Care (2012) 1.01
Immunogenicity and safety of the eleven valent pneumococcal polysaccharide-protein D conjugate vaccine in infants. Pediatr Infect Dis J (2004) 1.01
Anti-PsaA and the risk of pneumococcal AOM and carriage. Vaccine (2003) 1.01
Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial. Infect Immun (2007) 1.01
Breastfeeding patterns of mothers with type 1 diabetes: results from an infant feeding trial. Diabetes Metab Res Rev (2010) 1.01
Relation of positive T wave in lead aVR to risk of cardiovascular mortality. Am J Cardiol (2011) 1.01
Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis (2002) 1.00
Obesity and unhealthy life-years in adult Finns: an empirical approach. Arch Intern Med (2004) 1.00
A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med (2005) 1.00
Antibodies to pneumococcal proteins PhtD, CbpA, and LytC in Filipino pregnant women and their infants in relation to pneumococcal carriage. Clin Vaccine Immunol (2009) 0.99
Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera. Clin Vaccine Immunol (2010) 0.99
Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines. Clin Vaccine Immunol (2010) 0.98
Evolution of conjugate vaccines. Expert Rev Vaccines (2002) 0.98
Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination. J Pediatr (2010) 0.98
Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis (2008) 0.97
Is there any specific association between respiratory viruses and bacteria in acute otitis media of young children? J Infect (2005) 0.96
Prevalence of major eye diseases and causes of visual impairment in the adult Finnish population: a nationwide population-based survey. Acta Ophthalmol (2009) 0.96
Socioeconomic inequities in invasive cardiac procedures among patients with incident angina pectoris or myocardial infarction. Scand J Public Health (2006) 0.95
Long-term persistence of immunity after immunisation with Haemophilus influenzae type b conjugate vaccine. Vaccine (2003) 0.95
Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infect Immun (2010) 0.93
Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab (2006) 0.93
Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr Allergy Immunol (2007) 0.93